COMFORTIS (spinosad) is available in six sizes of chewable flavored tablets for oral administration to dogs and puppies according to their weight. Each chewable tablet is formulated to provide a minimum spinosad dosage of 13.5 mg/lb (30 mg/kg).
The IQ-achievement discrepancy model assesses whether there is a significant difference between a studentâs scores on a test of general intelligence (e.g., an IQ test such as the WISC-IV) and scores obtained on an achievement test (e.g., the Woodcock Johnson Achievement Test).
In the discrepancy model, a student receives special education services for a specific learning difficulty (SLD) if the student has at least normal intelligence and the student's academic achievement is below what is expected of a student with his or her IQ.